Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Annual Review of Pharmacology and Toxicology|August 9, 2011
Chemical genetics-based target identification in drug discoveryFeng Cong, Atwood K Cheung, Shih-Min A Huang
Plos One|September 4, 2009
Negative regulators of insulin signaling revealed in a genome-wide functional screenShih-Min A Huang, Michael K Hancock, Jeffrey L Pitman, et al.
NPJ Systems Biology and Applications|September 8, 2017
Erratum: Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
NPJ Systems Biology and Applications|June 27, 2017
Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
The Journal of Biological Chemistry|November 28, 2012
Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradationYang Xie, Monika Avello, Markus Schirle, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2020
Discovery of SARxxxx92, a pan-PIM kinase inhibitor, efficacious in a KG1 tumor modelClaude Barberis, Paul Erdman, Mark Czekaj, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2018
Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors - Lead optimization - Part IIIClaude Barberis, James Pribish, Elina Tserlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2019
A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid TumorsAndrea Varga, Jean-Charles Soria, Antoine Hollebecque, et al.
Nature Cell Biology|April 12, 2011
RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signallingYue Zhang, Shanming Liu, Craig Mickanin, et al.
Oncotarget|May 17, 2014
Combination of PIM and JAK2 inhibitors synergistically suppresses MPN cell proliferation and overcomes drug resistanceShih-Min A Huang, Anlai Wang, Rita Greco, et al.
Pageof 3